Eventually, it was found that seven targets of AP-2α (KRT1, COL7A1, TMEM59L, KRT14, SLC12A5, GRIA1, SEZ6L) were of prognostic importance for patients having BLCA, LUAD, LUSC or PAAD. This evidence concerns the gene TMEM59L and bladder transitional cell carcinoma.